Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro

  • 24 Accesses

  • 185 Citations


Following activationin vitro, peripheral blood mononuclear cells (PBMC) express cell-associated interleukin-2 receptors (IL-2R) and also release soluble IL-2R into culture supernatants. The present studies were undertaken to define which normal cells were responsible for the release of soluble IL-2Rin vitro. Both cell-associated and soluble IL-2R were quantitatively measured with a “sandwich” enzyme-linked immunoassay employing two monoclonal antibodies. PBMC were separated into populations of surface immunoglobulin-negative cells (T cells and monocytes) and surface immunoglobulin-positive cells (B cells and monocytes), and the T-cell population was further separated into OKT4-positive (OKT4+) cells and OKT4-negative (OKT4) cells. Following activation with phytohemagglutinin, pokeweed mitogen, and the monoclonal antibody OKT3, large amounts of soluble IL-2R were released by PBMC, unseparated T cells, OKT4+ T cells, and OKT4 T cells. The population containing B cells and monocytes made small but readily detectable amounts of soluble IL-2R when stimulated with these T-cell mitogens; likely the result of contaminating T cells in the population. However, when highly purified B cells were stimulated withStaphylococcus aureus Cowan and recombinant IL-2, they also released small amounts of soluble IL-2R. The release of soluble IL-2R by T cells appeared monocyte dependent when OKT3, but not phytohemagglutinin, was employed for activation, and monocytes themselves released no detectable IL-2R under the conditions employed. These studies define the cellular requirements for the release of soluble IL-2Rin vitro and demonstrate that such receptors are released by B cells, T cells, and both OKT4+ and OKT4 T-cell subsets.

This is a preview of subscription content, log in to check access.


  1. 1.

    Cantrell DA, Smith KA: The interleukin-2 T-cell system: A new cell growth model. Science 224:1312–1316, 1984

  2. 2.

    Leonard WJ, Depper JM, Robb RJ, Waldmann TA, Greene WC: Characterization of the human receptor for T cell growth factor. Proc Natl Acad Sci USA 80:6957–6961, 1983

  3. 3.

    Tsudo M, Uchiyama T, Uchino H: Expression of Tac antigen on activated normal human B cells. J Exp Med 160:612–617, 1984

  4. 4.

    Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Greene WC: Expression of interleukin-2 receptors on activated B cells. J Exp Med 160:1450–1466, 1984

  5. 5.

    Moll H, Emmrich F, Simon MM: Recombinant human interleukin 2 directly provides signals for the proliferation and functional maturation of murine B lymphocytes. Immunobiology 169:447–454, 1985

  6. 6.

    Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL: Soluble interleukin-2 receptors are released from activated human lymphoid cellsin vitro. J Immunol 135:3172–3177, 1985

  7. 7.

    Rubin LA, Kurman CC, Fritz ME, Nelson DL: Serum levels of soluble interleukin-2 receptor are elevated in patients with certain lymphoreticular malignancies. Clin Res 33:457A, 1985

  8. 8.

    Uchiyama T, Broder S, Waldmann TA: A monoclonal antibody reactive with activated and functionally mature human T cells. J Immunol 126:1393–1397, 1981

  9. 9.

    Rubin LA, Kurman CC, Biddison WE, Goldman ND, Nelson DL: A monoclonal antibody, 7G7/B6, that binds to an epitope on the human IL-2 receptor distinct from that recognized by IL-2 or anti-Tac. Hybridoma 4:91–102, 1985

  10. 10.

    Shaw S, Nelson DL, Shearer GM: Human cytotoxic responsein vitro to trinitrophenyl-modified autologous cells. I. T-cell recognition of TNP in association with widely shared antigens. J Immunol 121:281–289, 1978

  11. 11.

    Nelson DL, Bundy BM, Pitchon HE, Blaese RM, Strober W: The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependency cellular cytotoxicity. J Immunol 117:1472–1481, 1976

  12. 12.

    Uchiyama T, Nelson DL, Fleisher TA, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol 26:1398–1403, 1981

  13. 13.

    Kirchner H, Tosato G, Blaese RM, Broder S, Magrath, IT: Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virusin vitro. J Immunol 122:1310–1313, 1979

  14. 14.

    Chien MM, Ashman RF: Rapid separation of human monocytes and lymphocytes by Sephadex G-10. J Immunol Methods 71:25–36, 1984

  15. 15.

    Yarchoan R, Barrow LA, Kurman CC, Strober W, Nelson DL: Human peripheral blood mononuclear cells produce IgA antiinfluenza virus antibody in a secondaryin vitro antibody response. J Immunol 135:1033–1039, 1985

  16. 16.

    Bundy BM: Studies of the Requirement for Adherent Cells as Accessory Cells in the Specific Cytotoxic Response of the Human Mixed Lymphocytes Culture PhD thesis. Washington, DC, George Washington University, 1982

  17. 17.

    Herrmann F, Cannistra SA, Levine H, Griffin JD: Expression of IL-2 receptors and binding of IL-2 by gamma-interferon induced human leukemic and normal monocytic cells. J Exp Med 162:1111–1114, 1985

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nelson, D.L., Rubin, L.A., Kurman, C.C. et al. An analysis of the cellular requirements for the production of soluble interleukin-2 receptorsin vitro . J Clin Immunol 6, 114–120 (1986).

Download citation

Key words

  • Interleukin-2
  • interleukin-2 receptor
  • lymphocyte subsets
  • lymphocyte activation